Yong Yu, VP, Clinical Trial Operations at GENELUX Corp (GNLX), sold 5,200 shares at $21.94 ($114K) on 2023-10-10, disclosed to the SEC on 2023-10-11.
Open-market sale of $114k GNLX by VP, Clinical Trial Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.94 | 4,800 | $105K | 92.0% |
| 2 | $22.91 | 400 | $9K | 8.0% |
| Total | $22.01 avg | 5,200 | $114K | 100% |
| Filing → |
| GNLX | SELL | 2026-05-12 | $2K | — | Filing → |
| GNLX | SELL | 2026-03-26 | $2K | — | Filing → |
| GNLX | SELL | 2025-12-11 | $16K | — | Filing → |